Overview
Afshin Sam is an Intensive Care Medicine provider practicing medicine in Duarte, California.
Dr. Sam is highly rated in 3 conditions, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Lung Nodules, Emphysema, Beryllium Disease, and Bone Marrow Aspiration.
He is actively involved in clinical research, co-authoring 10 peer reviewed articles and participating in 1 clinical trial. Dr. Sam is currently accepting new patients.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 Duarte Rd, Duarte, CA 91010
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Office
Igor Barjaktarevic is an Intensive Care Medicine provider practicing medicine in Los Angeles, California. Dr. Barjaktarevic is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Emphysema, Liver Failure, Lung Nodules, Thrombectomy, and Endoscopy. Dr. Barjaktarevic is currently accepting new patients.
UC Irvine Medical Center
Dr. Adithya Cattamanchi is a board-certified UCI Health pulmonologist who specializes in lung disorders and critical care medicine. His clinical focus is on the treatment and management of pulmonary infections as well as common lung diseases, such as asthma and chronic obstructive pulmonary disease (COPD).Cattamanchi earned his medical degree at the UC San Francisco School of Medicine, where he completed a residency in internal medicine and a fellowship in pulmonary and critical care medicine. He also received a master's of science degree in clinical research at UC San Francisco. Before joining UCI Health and the UC Irvine School of Medicine as chief of the Division of Pulmonary Diseases & Critical Care Medicine, he served as a pulmonologist and critical care medicine specialist at Zuckerberg San Francisco General Hospital and Trauma Center and as a professor with the UC San Francisco School of Medicine and its Center for Tuberculosis.His research focus is on improving the diagnosis and treatment of people with tuberculosis (TB) to ensure that the disease is diagnosed early and treatment begun immediately for better outcomes and to prevent community transmission, particularly in regions around the world with high rates of TB. Working with basic scientists and engineers to identify novel biomarkers for TB screening and diagnosis, he has developed point-of-care platforms for biomarker detection and tested them in field studies to evaluate their impact on clinical decisions and patient outcomes.Cattamanchi is the author or co-author of nearly 200 articles in peer-reviewed medical journals. His published research includes the performance of TB diagnostics among people with TB and led studies funded by the National Institutes of Health (NIH) to increase molecular testing for TB in community health centers throughout Uganda and to improve molecular diagnosis of drug-resistant TB in the Philippines. He also is working on NIH-funded studies to reduce TB in high-density U.S. urban settings and to develop novel, noninvasive tests to diagnose TB in children. Dr. Cattamanchi is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Pulmonary Tuberculosis, Pneumonia, Pneumocystis Jiroveci Pneumonia, and COVID-19. Dr. Cattamanchi is board certified in American Board Of Internal Medicine - Pulmonary Disease.
Office
John Belperio is an Intensive Care Medicine provider practicing medicine in Los Angeles, California. Dr. Belperio is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Pulmonary Fibrosis, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Systemic Sclerosis (SSc), and Lung Nodules. Dr. Belperio is currently accepting new patients.
Frequently Asked Questions about Dr. Afshin R. Sam
How do I make an appointment with Dr. Afshin R. Sam?
You can book an appointment with Dr. Afshin R. Sam by calling their office at 866-461-6206. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Afshin R. Sam a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Afshin R. Sam is classified as an Advanced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Afshin R. Sam specialize in?
While Dr. Afshin R. Sam is a Intensive Care Medicine, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer, Lung Nodules, and Emphysema. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Intensive Care Medicine.
Does Dr. Afshin R. Sam participate in research or clinical trials?
Yes. Dr. Afshin R. Sam has published 10 articles and abstracts on conditions like ALK-Positive Non-Small Cell Lung Cancer. You can view a list of Dr. Afshin R. Sam's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Afshin R. Sam accept my insurance?
Dr. Afshin R. Sam accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 866-461-6206 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- EmphysemaDr. Sam isAdvanced. Learn about Emphysema.
- Lung NodulesDr. Sam isAdvanced. Learn about Lung Nodules.
- Experienced
- Beryllium DiseaseDr. Sam isExperienced. Learn about Beryllium Disease.
- Bone Marrow AspirationDr. Sam isExperienced. Learn about Bone Marrow Aspiration.
- Chronic Graft Versus Host Disease (cGvHD)
- Classical Hodgkin LymphomaDr. Sam isExperienced. Learn about Classical Hodgkin Lymphoma.
- Febrile NeutropeniaDr. Sam isExperienced. Learn about Febrile Neutropenia.
- Myeloproliferative Neoplasms (MPN)
- Nontuberculous Mycobacterial Lung Disease
- Pediatric Low-Grade Glioma (pLGG)Dr. Sam isExperienced. Learn about Pediatric Low-Grade Glioma (pLGG).
- Pulmonary FibrosisDr. Sam isExperienced. Learn about Pulmonary Fibrosis.
- Relapsed Refractory Multiple Myeloma (RRMM)
- Smoldering Multiple MyelomaDr. Sam isExperienced. Learn about Smoldering Multiple Myeloma.
- Systemic Sclerosis (SSc)Dr. Sam isExperienced. Learn about Systemic Sclerosis (SSc).
